×
0 -0.00371747211895903 -0.0557620817843866 -0.0594795539033456 -0.0966542750929367 -0.0780669144981413 -0.0966542750929367 -0.159851301115242
Stockreport

FDA signs off on registration study of Capricor's DMD candidate CAP-1002; shares up 34% premarket [Seeking Alpha]

CAPRICOR THERAPEUTICS (CAPR)  More Company Research Source: Seeking Alpha
Last capricor therapeutics earnings: 8/9 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF FDA signs off on registration study of Capricor's DMD candidate CAP-1002; shares up 34% premarketNano cap Capricor Therapeutics (NASDAQ:CAPR) is up34% premarket on modestly higher volume in response to itsannouncement that the FDA has approved its IND to conduct a new clinical trial, HOPE-2, assessing CAP-1002 in boys and young men with Duchenne muscular dystrophy (DMD).If successful, the data will support a U.S. marketing application. The trial should be initiated next quarter.HOPE-2 will enroll ~84 subjects. The primary endpoint will be the change from baseline in the mid-level dimension of the Performance of the Upper Limb test at month 12.CAP-1002 is an investigational allogeneic, off-the-shelf cardiac cell therapy derived from donor heart tissue and infused directly into the patient's coronary artery via a catheter.Management will host a conference call today at 4:30 pm ET to discuss the study.Previously:Capricor announces positive 12-month data on DMD candidate CAP-1002; investo [Read more]

IMPACT SNAPSHOT EVENT TIME: CAPR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CAPR alerts

from News Quantified
Opt-in for
CAPR alerts

from News Quantified